Skip to Content

Otezla Side Effects

Generic Name: apremilast

Note: This document contains side effect information about apremilast. Some of the dosage forms listed on this page may not apply to the brand name Otezla.

In Summary

Common side effects of Otezla include: weight loss. Other side effects include: diarrhea, headache, and nausea. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to apremilast: oral tablet

Along with its needed effects, apremilast (the active ingredient contained in Otezla) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking apremilast:

Rare
  • Changes in behavior
  • discouragement
  • feeling sad or empty
  • irritability
  • lack of appetite
  • loss of interest or pleasure
  • thoughts of killing oneself
  • tiredness
  • trouble concentrating
  • trouble sleeping
Incidence not known
  • Fast heartbeat
  • fever
  • hives, itching, rash
  • hoarseness
  • irritation
  • joint pain, stiffness, or swelling
  • redness of the skin
  • swelling of the eyelids, face, lips, hands, or feet
  • tightness in the chest
  • troubled breathing or swallowing
  • weight loss

Some side effects of apremilast may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common Less common

For Healthcare Professionals

Applies to apremilast: oral tablet

General

The most commonly reported side effects included diarrhea, headache, and nausea.[Ref]

Hypersensitivity

Frequency not reported: Hypersensitivity[Ref]

Gastrointestinal

Common (1% to 10%): Diarrhea, nausea, vomiting, upper abdominal pain
Frequency not reported: Frequent bowel movement, gastroesophageal reflux disease, dyspepsia[Ref]

Respiratory

Common (1% to 10%): Upper respiratory tract infection, nasopharyngitis
Frequency not reported: Cough[Ref]

Dermatologic

Frequency not reported: Rash[Ref]

Metabolic

Frequency not reported: Weight decrease, decreased appetite[Ref]

Nervous system

Common (1% to 10%): Headache
Frequency not reported: Migraine[Ref]

References

1. "Product Information. Otezla (apremilast)." Celgene Corporation, Summit, NJ.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide